Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

NCT04312698 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia Patients With Hypertension

Interventions

DRUG: D013, D326, D337
DRUG: placebo of D013, D326, D337
DRUG: D013, placebo of D326, placebo of D337

Sponsor

Chong Kun Dang Pharmaceutical